Jazz Pharmaceuticals (NASDAQ: JAZZ) awards 1,605 RSUs to director Kennedy

Rhea-AI Filing Summary

Kennedy Patrick reported acquisition or exercise transactions in this Form 4 filing.

Jazz Pharmaceuticals director Patrick Kennedy reported a grant of 1,605 restricted stock units, each representing one ordinary share, under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to continuous service and conditions, the units vest in full on July 23, 2027, bringing his direct holdings to 8,307 ordinary shares.

Insider Trade Summary

Net Buyer: 1,605 shares

Net Buy 1 txn

Insider Kennedy Patrick

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 8,307 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

Restricted stock units granted: 1,605 shares Holdings after transaction: 8,307 shares Vesting date: July 23, 2027 +1 more

4 metrics

Restricted stock units granted 1,605 shares Grant of restricted stock units to director Patrick Kennedy

Holdings after transaction 8,307 shares Total ordinary shares directly held by Patrick Kennedy after the grant

Vesting date July 23, 2027 Date when the 1,605 restricted stock units vest in full, subject to conditions

Transaction price per share 0.0000 No-cash-cost equity award of restricted stock units

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary"

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional"

Non-Employee Directors Stock Award Plan financial

"Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:49 PM Accepted by SEC EDGAR 08/07/2026 - 05:48 PM Learn about SEC filing dates

FAQ

What insider transaction did Patrick Kennedy report for Jazz Pharmaceuticals (JAZZ)?

Patrick Kennedy reported a grant of 1,605 restricted stock units in Jazz Pharmaceuticals, each convertible into one ordinary share. The grant is part of the 2007 Non-Employee Directors Stock Award Plan and vests in full on July 23, 2027.

How many Jazz Pharmaceuticals (JAZZ) shares does Patrick Kennedy hold after this grant?

After the reported grant, Patrick Kennedy directly holds 8,307 ordinary shares of Jazz Pharmaceuticals. This total reflects the addition of 1,605 restricted stock units, which each represent a contingent right to receive one ordinary share upon vesting.

What are the vesting terms of Patrick Kennedy’s new Jazz (JAZZ) restricted stock units?

The 1,605 restricted stock units granted to Patrick Kennedy vest in full on July 23, 2027, subject to his continuous service and certain additional conditions. Each vested unit will deliver one ordinary share of Jazz Pharmaceuticals.

Under which plan were Patrick Kennedy’s Jazz (JAZZ) restricted stock units granted?

The award was granted under Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan. This plan provides equity compensation to non-employee directors through restricted stock units, each representing a right to receive one ordinary share at vesting.

Did Patrick Kennedy pay a purchase price for the new Jazz (JAZZ) shares?

The filing lists a per-share transaction price of 0.0000, indicating a no-cash-cost grant of restricted stock units as director compensation. The economic value comes from future delivery of shares once the units vest in 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Patrick

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		A(1)		1,605	A	$0.0	8,307	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Patrick Kennedy	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)